Cognitive impact on patients with COVID-19 infection

The Egyptian Journal of Bronchology

Table 3 Comorbidities and SpO₂ level of the studied patients based on the severity of illness and site of care

	ICU group (n=20)	Ward group (n=20)	Home isolation (n=20)	P1	P2	P3	P4
Cardiac
No	16 (80%)	15 (75%)	17 (85%)	0.653	0.681	0.677	0.061
Yes	4 (20%)	5 (25%)	3 (15%)	0.653	0.681	0.677	0.061
Renal
Non-renal	17 (85%)	17 (85%)	18 (90%)	0.669	0.632	0.632	0.645
Renal	3 (15%)	3 (15%)	2 (10%)	0.669	0.632	0.632	0.645
Hepatic
Non-hepatic	18 (90%)	19 (95%)	18 (90%)	0.5	0.698	0.545	0.069
Hepatic	2 (10%)	1 (5%)	2 (10%)	0.5	0.698	0.545	0.069
Diabetes
Non-diabetic	13 (65%)	16 (80%)	13 (65%)	0.240	0.629	0.288	0.154
Diabetic	7 (35%)	4 (20%)	7 (35%)	0.240	0.629	0.288	0.154
Hypertension
No	16 (80%)	14 (70%)	13 (65%)	0.653	0.288	0.325	0.431
Yes	4 (20%)	6 (30%)	7 (35%)	0.653	0.288	0.325	0.431
SpO₂
Mean ± SD	73.4 ± 12	86.90±3.87	93.7 ± 2.13	0.002*	<0.001*	0.003*	<0.001*
Need for HFNC	5 (25%)	-----------	-----------

Continuous data were expressed in the form of the mean (± SD) and compared by the Mann-Whitney test and Kruskal-Wallis test for groups of more than two, while nominal data were expressed in the form of frequency (percentage) and compared by χ² tests. The P value was significant if < 0.05
P1 P value between ICU and ward groups, P2 P value between ICU and home isolation group, P3 P value between ward and home isolation groups, P4 P value between the three groups, * indicates a highly significant p-value